Therapeutic and pharmacological effects of second-generation antipsychotics on drug-resistant bipolar depression
Kuroki, T.; Kaminiwa, S.; Haeno, M.; Kohara, K.; Ninomiya, H.
Seishin Shinkeigaku Zasshi 106(8): 1025-1029
2004
ISSN/ISBN: 0033-2658 PMID: 15655899 Document Number: 568815
Document emailed within 1 workday
Related Documents
Dudek, D.; Siwek, M.; Borowiecka-Kluza, J. 2008: The analysis of bipolar spectrum features in drug resistant unipolar depression patients as compared to depressive patients who responded to standard antidepressant treatment. a pilot study Psychiatria Polska 42(2): 283-294Piepho, R.W. 2002: Cardiovascular effects of antipsychotics used in bipolar illness Journal of Clinical Psychiatry 63(Suppl): 20-23
Hu, Y.-H.; Guo, J.-C.; Zhang, M. 2017: Bipolar androgen therapy: a novel therapeutic strategy for castration-resistant prostate cancer Zhonghua Nan Ke Xue 23(12): 1138-1140
Karadağ, F.; Tan, D.; Unal, F. 2011: Aripiprazole augmentation treatment in treatment resistant bipolar depression: two patient reports Turk Psikiyatri Dergisi 22(4): 269-272
Urquhart, J. 1984: Pharmacological and therapeutic aspects of drug administration by rate-controlled drug delivery systems: steady-state pharmacology Bollettino Chimico Farmaceutico 123(4): 155-168
Taiminen, T. 2013: Treatment of drug-resistant depression Duodecim; Laaketieteellinen Aikakauskirja 129(20): 2149-2156
Suwalska, A.; Rybakowski, J. 1996: Biological mechanisms of drug-resistant depression Psychiatria Polska 30(5): 713-729
Wager, S.G.; Klein, D.F. 1988: Drug therapy strategies for treatment-resistant depression Psychopharmacology Bulletin 24(1): 69-74
Kielholz, P. 1990: Treatment of drug-resistant depression by intravenous administration of antidepressants Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 90(4): 53-56
Koszewska, I. 1996: Pharmacotherapy of depression in patients with and without conversion from depression to mania in the course of bipolar affective disorder Psychiatria Polska 30(1): 99-111
Krawczyk, K.; Rybakowski, J. 2012: Augmentation of antidepressants with unsaturated fatty acids omega-3 in drug-resistant depression Psychiatria Polska 46(4): 585-598
Radziwoń-Zaleska, M.; Matsumoto, H.; Skalski, M.; Androsiuk, W.; Dziklińska, A.; Kunicki, P.K. 2000: Therapeutic drug monitoring in depression Polish Journal of Pharmacology 52(4): 255-266
Mahendran, R.; Hendricks, M.; Chan, Y.H. 2010: Weight gain in Asian patients on second-generation antipsychotics Annals of the Academy of Medicine Singapore 39(2): 118-121
Francesco, F.; Cervone, A. 2014: Metabolic alterations associated with first and second generation antipsychotics: an twenty-years open study Psychiatria Danubina 26(Suppl 1): 184-187
Wyszogrodzka-Kucharska, A.; Rabe-Jabłońska, J. 2005: Decrease in mineral bone density in schizophrenic patients treated with 2nd generation antipsychotics Psychiatria Polska 39(6): 1173-1184
Czyrak, A.; Skuza, G.; Rogóz, Z.; Frankiewicz, T.; Maj, J. 1994: Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes Arzneimittel-Forschung 44(2): 113-118
Johnson, G.F.; Wilson, P. 1989: The management of depression: a review of pharmacological and non-pharmacological treatments Medical Journal of Australia 151(7): 397-400 403 406
Dziedzicka-Wasylewska, M.; Rogóz, Z.; Solich, J.; Dudek, D.; Wróbel, A.; Zieba, A. 2002: Effect of joint administration of imipramine and amantadine on binding of [3H]7-OH-DPAT to dopamine D3 receptors in peripheral blood lymphocytes of the patients with drug-resistant unipolar depression Polish Journal of Pharmacology 54(6): 703-706
Finke, G.; Wegener, G. 1982: Comparison of the therapeutic effects of lofepramine and maprotiline in depression Münchener Medizinische Wochenschrift 124(12): 301-303
Rayikanti, R.; Lentowicz, I.; Birur, B.; Li, L. 2017: Combined Antipsychotics and Electroconvulsive Therapy in an Acutely Psychotic Patient with Treatment-resistant Schizophrenia Psychopharmacology Bulletin 47(2): 57-62